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Oral drug delivery systems are the most common route of administration. However, 
development oral delivery system containing macromolecules is still challenging due to 
different hurdles, including, digestive enzymes degradation and physiochemical 
properties of the molecules. Currently, several techniques have been applied to deliver 
the macromolecules orally e.g. polymer conjugates, excipients such as cyclodextrin, and 
entrapment inside carriers, such as liposomes, and nanocapsule systems. Accordingly, the 
aim of this study is to overcome these challenges by encapsulating macromolecule inside 
polymeric nanocapsules, trypsin as a protein was used as a model macromolecule. 
 
The polymeric nanocapsules were prepared by double emulsion method s/o/w or w/o/w 
based on the quality by design (QbD) concepts. Critical quality attributes (CQA), were 
determined in order to achieve the quality target product profile (QTPP). The 
formulations were developed by using Poly(DL-lactide-co-caprolactone) copolymers in 
two different ratios (86:14, and 40:60) IRUODFWLGHDQGڙ-caprolactone blocks, respectively. 
Trehalose was encapsulated with some formulations. Table1 shows the full experimental 
design consisting of eight formulations. Nanocapsules morphology and particle size were 
investigated by Transmission Electron Microscope, and Dynamic Light Scattering, 
respectively. The entrapment efficiency of nanocapsules, the effect of the polymer and 
preparation procedures on trypsin activity and the release profile in simulated gastric 
fluid SGF and simulated intestinal fluid SIF were assessed.  
 
 
 
 
 
 
 
Table1: Design of experiment combining different factors at different levels to prepare eight different formulations 
containing trypin. 
 
Applying QbD saved the resources, and provided huge useful results within short time. 
Nanocapsules were spherical with no distortion, Figure 1. The encapsulation efficiency 
has reached up to 80.7%, and it has been affected significantly (P 0.005) by the 
copolymer blocks ratio. Moreover, the drug release profile in SIF over 24 hours was 
affected by the copolymer ratios, with released drug up to 64.01% in a triphasic pattern 
concluded in the following three steps; the first burst phase with 8% release within 15 
minutes, then a plateau for 8 ± 10 hours, finally trypsin started to release in a sustained 
rate over the rest of 24 hours, whilst the release in SGF reached 8% in average; which can 
protect the macromolecules from the gastric enzymes degradation. Trypsin biological 
activity was affected by the materials and the process parameters and retained only 18% 
of the original activity. However, adding trehalose and encapsulation of solid protein 
helped the protein to retain up to 84.65% of the original activity.  
Formulation ڙ- Caprolactone ratio Core physical state Trehalose mM 
F1 14% Liquid 0 
F2 60% Liquid 0 
F3 14% Solid 0 
F4 60% Solid 0 
F5 14% Liquid 10 
F6 60% Liquid 10 
F7 14% Solid 10 
F8 60% Solid 10 
 Figure 1: TEM image of one of nanocapsules formulations.  
 
In conclusion, polymeric nanocapsules showed promising results to potentially deliver 
active protein orally in the presence of trehalose especially when it was prepared by 
s/o/w, and when the copolymer blocks ratio was optimised. The applied rationale could 
be applicable to further macromolecules including monoclonal antibodies, genes, and 
cells, in order to obtain close quality attributes. 
 
